Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammography | 13 | 2016 | 463 | 2.210 |
Why?
|
| Diagnosis, Computer-Assisted | 11 | 2018 | 332 | 2.150 |
Why?
|
| ROC Curve | 15 | 2020 | 752 | 2.150 |
Why?
|
| Breast Neoplasms | 15 | 2020 | 2903 | 1.800 |
Why?
|
| Ultrasonography, Mammary | 4 | 2018 | 82 | 1.260 |
Why?
|
| Image Interpretation, Computer-Assisted | 9 | 2020 | 663 | 1.220 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2020 | 3362 | 1.070 |
Why?
|
| Artificial Intelligence | 4 | 2020 | 298 | 0.890 |
Why?
|
| Sensitivity and Specificity | 17 | 2020 | 1991 | 0.760 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2020 | 1204 | 0.740 |
Why?
|
| Prostatic Neoplasms | 14 | 2019 | 1721 | 0.730 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 4 | 2010 | 466 | 0.730 |
Why?
|
| Models, Statistical | 5 | 2013 | 574 | 0.690 |
Why?
|
| Calcinosis | 5 | 2007 | 224 | 0.640 |
Why?
|
| Breast Density | 1 | 2018 | 31 | 0.640 |
Why?
|
| Algorithms | 7 | 2013 | 1830 | 0.630 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 9 | 2019 | 294 | 0.620 |
Why?
|
| Image Enhancement | 7 | 2020 | 563 | 0.620 |
Why?
|
| Prostate | 6 | 2016 | 378 | 0.590 |
Why?
|
| Pattern Recognition, Automated | 4 | 2005 | 217 | 0.580 |
Why?
|
| Breast Diseases | 3 | 2006 | 97 | 0.520 |
Why?
|
| Contrast Media | 12 | 2020 | 1078 | 0.500 |
Why?
|
| Multimodal Imaging | 4 | 2016 | 110 | 0.490 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2013 | 201 | 0.480 |
Why?
|
| Axilla | 1 | 2013 | 99 | 0.460 |
Why?
|
| Monte Carlo Method | 4 | 2020 | 185 | 0.430 |
Why?
|
| Observer Variation | 8 | 2016 | 602 | 0.430 |
Why?
|
| Lymphatic Metastasis | 1 | 2013 | 486 | 0.410 |
Why?
|
| Reproducibility of Results | 10 | 2020 | 2705 | 0.400 |
Why?
|
| Area Under Curve | 5 | 2013 | 334 | 0.390 |
Why?
|
| Retrospective Studies | 16 | 2020 | 8489 | 0.370 |
Why?
|
| Gadolinium DTPA | 7 | 2014 | 261 | 0.350 |
Why?
|
| Radiologists | 2 | 2019 | 46 | 0.340 |
Why?
|
| Quality Assurance, Health Care | 1 | 2010 | 220 | 0.330 |
Why?
|
| Female | 22 | 2020 | 44532 | 0.310 |
Why?
|
| Lung Neoplasms | 5 | 2019 | 2262 | 0.310 |
Why?
|
| Diagnosis, Differential | 7 | 2020 | 1565 | 0.310 |
Why?
|
| Mass Screening | 2 | 2015 | 618 | 0.310 |
Why?
|
| Humans | 43 | 2020 | 86643 | 0.300 |
Why?
|
| Tumor Burden | 4 | 2016 | 289 | 0.300 |
Why?
|
| Subtraction Technique | 2 | 2005 | 133 | 0.300 |
Why?
|
| Computer Simulation | 6 | 2013 | 1078 | 0.300 |
Why?
|
| Epidemiologic Research Design | 1 | 2007 | 22 | 0.300 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2019 | 2601 | 0.300 |
Why?
|
| Precancerous Conditions | 2 | 2005 | 196 | 0.290 |
Why?
|
| Middle Aged | 21 | 2020 | 25028 | 0.280 |
Why?
|
| Radiology | 2 | 2016 | 194 | 0.260 |
Why?
|
| Aged | 20 | 2019 | 18415 | 0.260 |
Why?
|
| Positron-Emission Tomography | 3 | 2016 | 329 | 0.260 |
Why?
|
| User-Computer Interface | 1 | 2006 | 185 | 0.250 |
Why?
|
| Information Storage and Retrieval | 1 | 2004 | 120 | 0.240 |
Why?
|
| Registries | 1 | 2007 | 702 | 0.230 |
Why?
|
| Models, Theoretical | 1 | 2006 | 482 | 0.220 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2016 | 1075 | 0.210 |
Why?
|
| Clinical Trials as Topic | 1 | 2007 | 1169 | 0.210 |
Why?
|
| Likelihood Functions | 3 | 2016 | 251 | 0.200 |
Why?
|
| Aged, 80 and over | 6 | 2018 | 6509 | 0.200 |
Why?
|
| Automation | 2 | 2018 | 106 | 0.190 |
Why?
|
| Early Detection of Cancer | 3 | 2019 | 394 | 0.180 |
Why?
|
| Radiographic Image Enhancement | 3 | 2007 | 462 | 0.180 |
Why?
|
| Radiography, Thoracic | 2 | 2016 | 320 | 0.180 |
Why?
|
| Bayes Theorem | 2 | 2012 | 361 | 0.180 |
Why?
|
| Prostatectomy | 7 | 2019 | 471 | 0.170 |
Why?
|
| Breast | 1 | 2020 | 288 | 0.170 |
Why?
|
| Lupus Nephritis | 2 | 2016 | 78 | 0.160 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2016 | 579 | 0.160 |
Why?
|
| Adult | 13 | 2018 | 25648 | 0.160 |
Why?
|
| Predictive Value of Tests | 4 | 2016 | 1673 | 0.150 |
Why?
|
| Nephritis, Interstitial | 1 | 2016 | 47 | 0.140 |
Why?
|
| Probability | 2 | 2016 | 355 | 0.140 |
Why?
|
| Clinical Competence | 2 | 2019 | 751 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 189 | 0.130 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2016 | 128 | 0.130 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2016 | 138 | 0.130 |
Why?
|
| Whole Body Imaging | 1 | 2015 | 41 | 0.130 |
Why?
|
| Risk Assessment | 2 | 2019 | 2261 | 0.130 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2016 | 138 | 0.130 |
Why?
|
| Lymphocytes | 1 | 2016 | 464 | 0.120 |
Why?
|
| Male | 19 | 2019 | 40965 | 0.120 |
Why?
|
| Anatomic Landmarks | 1 | 2014 | 31 | 0.120 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2014 | 132 | 0.110 |
Why?
|
| Prostatic Hyperplasia | 2 | 2013 | 88 | 0.110 |
Why?
|
| Seminal Vesicles | 1 | 2013 | 39 | 0.110 |
Why?
|
| Carcinoma | 1 | 2016 | 436 | 0.110 |
Why?
|
| Inflammation | 2 | 2016 | 920 | 0.110 |
Why?
|
| Computer Graphics | 1 | 2012 | 100 | 0.100 |
Why?
|
| Neoplasm Staging | 2 | 2015 | 1939 | 0.100 |
Why?
|
| Kidney | 2 | 2016 | 1241 | 0.100 |
Why?
|
| Prostate-Specific Antigen | 1 | 2013 | 353 | 0.100 |
Why?
|
| Liver Diseases | 1 | 2013 | 238 | 0.100 |
Why?
|
| Neoplasm Grading | 3 | 2019 | 357 | 0.100 |
Why?
|
| Biopsy | 3 | 2019 | 1163 | 0.090 |
Why?
|
| Apoptosis | 1 | 2016 | 1683 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2015 | 912 | 0.090 |
Why?
|
| Time Factors | 1 | 2018 | 5210 | 0.090 |
Why?
|
| Radiography | 1 | 2010 | 813 | 0.080 |
Why?
|
| Liver | 1 | 2013 | 1230 | 0.080 |
Why?
|
| Software | 2 | 2015 | 654 | 0.070 |
Why?
|
| Cluster Analysis | 2 | 2004 | 369 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 736 | 0.070 |
Why?
|
| Normal Distribution | 1 | 2005 | 37 | 0.070 |
Why?
|
| Immunohistochemistry | 3 | 2016 | 1753 | 0.070 |
Why?
|
| Task Performance and Analysis | 1 | 2006 | 86 | 0.070 |
Why?
|
| Meglumine | 2 | 2016 | 39 | 0.060 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2004 | 33 | 0.060 |
Why?
|
| Organometallic Compounds | 2 | 2016 | 132 | 0.060 |
Why?
|
| Decision Making | 1 | 2009 | 642 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2016 | 839 | 0.060 |
Why?
|
| Quality Control | 1 | 2003 | 117 | 0.060 |
Why?
|
| Hair Follicle | 1 | 2002 | 26 | 0.050 |
Why?
|
| Research Design | 1 | 2006 | 594 | 0.050 |
Why?
|
| Alopecia | 1 | 2002 | 34 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2009 | 1169 | 0.050 |
Why?
|
| Receptors, Calcitriol | 1 | 2002 | 129 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 1801 | 0.040 |
Why?
|
| Risk | 1 | 2019 | 674 | 0.040 |
Why?
|
| Prognosis | 2 | 2016 | 3679 | 0.040 |
Why?
|
| Models, Biological | 1 | 2004 | 1749 | 0.040 |
Why?
|
| Mice, Inbred NZB | 1 | 2016 | 13 | 0.040 |
Why?
|
| Laser Capture Microdissection | 1 | 2016 | 20 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2019 | 751 | 0.040 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2016 | 22 | 0.040 |
Why?
|
| Palatine Tonsil | 1 | 2016 | 30 | 0.040 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2016 | 35 | 0.040 |
Why?
|
| Antigen-Antibody Complex | 1 | 2016 | 87 | 0.040 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2016 | 76 | 0.040 |
Why?
|
| Germinal Center | 1 | 2016 | 55 | 0.040 |
Why?
|
| Kidney Glomerulus | 1 | 2016 | 123 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 268 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2016 | 164 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 425 | 0.030 |
Why?
|
| Glycolysis | 1 | 2016 | 129 | 0.030 |
Why?
|
| Biological Transport | 1 | 2016 | 396 | 0.030 |
Why?
|
| United States | 1 | 2007 | 6672 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2016 | 300 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 927 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2001 | 3640 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2014 | 43 | 0.030 |
Why?
|
| Young Adult | 2 | 2016 | 5976 | 0.030 |
Why?
|
| Interleukins | 1 | 2014 | 134 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 2013 | 91 | 0.030 |
Why?
|
| Cell Communication | 1 | 2014 | 194 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2013 | 66 | 0.030 |
Why?
|
| Kinetics | 1 | 2016 | 1513 | 0.030 |
Why?
|
| Gadolinium | 1 | 2013 | 103 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 860 | 0.030 |
Why?
|
| Rectum | 1 | 2013 | 146 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 552 | 0.020 |
Why?
|
| Survival Rate | 1 | 2015 | 1863 | 0.020 |
Why?
|
| Computational Biology | 1 | 2014 | 528 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2016 | 1065 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2016 | 849 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 724 | 0.020 |
Why?
|
| Carcinoma, Ductal | 1 | 2007 | 18 | 0.020 |
Why?
|
| Mice | 2 | 2016 | 11352 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2013 | 2767 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 1186 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 1464 | 0.020 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2007 | 157 | 0.020 |
Why?
|
| Adolescent | 1 | 2016 | 8981 | 0.010 |
Why?
|
| Keratin-14 | 1 | 2002 | 5 | 0.010 |
Why?
|
| Keratins | 1 | 2002 | 63 | 0.010 |
Why?
|
| Transgenes | 1 | 2002 | 180 | 0.010 |
Why?
|
| Animals | 2 | 2016 | 26582 | 0.010 |
Why?
|
| Homeostasis | 1 | 2002 | 409 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2002 | 937 | 0.010 |
Why?
|
| Gene Expression | 1 | 2002 | 1284 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2002 | 1924 | 0.010 |
Why?
|
| Calcium | 1 | 2002 | 1156 | 0.010 |
Why?
|